Table 2.
Controls M0 |
Controls MI | ACD Seropositive |
ACD Seronegative |
GFD | Potential CD | |
---|---|---|---|---|---|---|
TOTAL | 353 | 57 | 194 | 14 | 195 | 15 |
% TCRγδ+ | ||||||
median | 4.8 | 5.5 | 21.35 | 35.25 | 25.5 | 30.6 |
Q1/Q3 | 2.6/9.2 | 2.1/10.7 | 16.1/30.2 | 19.4/48.8 | 18.7/36.2 | 25.1/41.2 |
min/max | 0.2/42.0 | 0.4/46.5 | 2.8/60.4 | 13.0/69.2 | 1.1/62.5 | 15.5/64.8 |
% sCD3− | ||||||
median | 15.5 | 10.9 | 0.8 | 1.4 | 4.3 | 1.4 |
Q1/Q3 | 8.7/25.7 | 5.6/15.0 | 0.5/1.4 | 0.9/2.2 | 1.5/8.9 | 0.7/6.7 |
min/max | 1.2/72.8 | 1.6/42.0 | 0.1/10.8 | 0.4/8.1 | 0.1/50.5 | 0.2/15.8 |
median | 0.3 | 0.6 | 23.8 | 22.3 | 6.5 | 19.4 |
Q1/Q3 | 0.1/0.9 | 0.2/1.2 | 13.5/55.1 | 10.0/43.0 | 2.5/20.2 | 8.8/58.9 |
min/max | 0.004/27.2 | 0.03/6.4 | 2.2/604 | 4.6/76.9 | 0.03/470 | 1.8/135.0 |
% TcRγδ+ and % sCD3− IEL densities are expressed as a percentage of the total intraepithelial lymphocytes. ACD, active celiac disease; CD, celiac disease; GFD, gluten-free diet; M0, Marsh type 0; and MI, Marsh type I.